炎症因子与肿瘤关系及其机制研究进展
Research Progress on the Relationship between Inflammatory Factors and Tumor and Its Mechanism
DOI: 10.12677/ACM.2021.1111715, PDF,  被引量   
作者: 徐 贺, 冶占明, 李 金, 张春泽:青海大学附属医院,肝胆胰外科,青海 西宁;王海久*:青海大学附属医院,肝胆胰外科,青海 西宁;青海省包虫病重点实验室,青海 西宁
关键词: 炎症指标肿瘤机制相关性Inflammatory Indicators Tumors Mechanisms Correlations
摘要: 炎症与肿瘤之间的关系密不可分,越来越多的证据表明炎症是肿瘤进展的关键组成部分,癌症多是由于感染部位慢性刺激和炎症而产生的。值得注意的是,炎症细胞在肿瘤微环境中起到了重要协调作用,是肿瘤过程中不可或缺的参与者,在促进肿瘤增殖、生存以及迁移等方面扮演了重要角色。此外,肿瘤的易感性和严重程度可能与炎症因子基因的功能多态性有关,炎症因子或许在肿瘤的免疫方面起着重要作用,因此探讨炎症指标与肿瘤之间的联系对深入了解肿瘤有着重大意义。
Abstract: The relationship between inflammation and tumors is inextricably linked, and there is growing evidence that inflammation is a key component of tumor progression. Cancer is often caused by chronic irritation and inflammation at the site of infection. It is noteworthy that inflammatory cells play an important coordinating role in the tumor microenvironment and are indispensable participants in the tumor process, playing an important role in promoting tumor proliferation, survival and migration. In addition, the susceptibility and severity of tumors may be related to the functional polymorphism of inflammatory factor genes, which may play an important role in tumor immunity. Therefore, it is of great significance to explore the relationship between inflammatory indicators and tumors for further understanding of tumors.
文章引用:徐贺, 冶占明, 李金, 张春泽, 王海久. 炎症因子与肿瘤关系及其机制研究进展[J]. 临床医学进展, 2021, 11(11): 4871-4876. https://doi.org/10.12677/ACM.2021.1111715

参考文献

[1] 刘宗超, 李哲轩, 张阳, 周彤, 张婧莹, 游伟程, 潘凯枫, 李文庆. 2020全球癌症统计报告解读[J]. 肿瘤综合治疗电子杂志, 2021, 7(2): 1-13.
[2] Qiu, H., Cao, S. and Xu, R. (2021) Cancer Incidence, Mortality, and Burden in China: A Time-Trend Analysis and Comparison with the United States and United Kingdom Based on the Global Epidemiological Data Released in 2020. Cancer Communications, 41, 1037-1048. [Google Scholar] [CrossRef] [PubMed]
[3] Balkwill, F. and Mantovani, A. (2001) Inflammation and Cancer: Back to Virchow? The Lancet, 357, 539-545. [Google Scholar] [CrossRef
[4] Weichman, B.M. (2005) Inflammation: Basic Principles and Clinical Correlates. Agents and Actions, 25, 205-206.
[5] Lira, S.A. and Furtado, G.C. (2012) The Biology of Chemokines and Their Receptors. Immunologic Research, 54, 111-120. [Google Scholar] [CrossRef] [PubMed]
[6] Homey, B., Müller, A. and Zlotnik, A. (2002) Chemokines: Agents for the Immunotherapy of Cancer? Nature Reviews Immunology, 2, 175-184. [Google Scholar] [CrossRef] [PubMed]
[7] Kuper, H., Adami, H.‐O. and Trichopoulos, D. (2001) Infections as a Major Preventable Cause of Human Cancer. Journal of Internal Medicine, 249, 61-74. [Google Scholar] [CrossRef
[8] Wahl, L.M. and Kleinman, H.K. (1998) Tumor-Associated Macrophages as Targets for Cancer Therapy. Journal of the National Cancer Institute, 90, 1583-1584. [Google Scholar] [CrossRef] [PubMed]
[9] Brigati, C., Noonan, D.M., Albini, A. and Benelli, R. (2002) Tumors and Inflammatory Infiltrates: Friends or Foes? Clinical and Experimental Metastasis, 19, 358-258. [Google Scholar] [CrossRef
[10] Tsung, K., Dolan, J.P., Tsung, Y.L. and Norton, J.A. (2002) Macrophages as Effector Cells in Interleukin 12-Induced T Cell-Dependent Tumor Rejection. Cancer Research, 62, 5069-5075.
[11] Schoppmann, S.F., Birner, P., Stöckl, J., Kalt, R., Ullrich, R., Caucig, C., Kriehuber, E., Nagy, K., Alitalo, K. and Kerjaschki, D. (2002) Tumor-Associated Macrophages Express Lymphatic Endothelial Growth Factors and Are Related to Peritumoral Lymphangiogenesis. The American Journal of Pathology, 161, 947-956. [Google Scholar] [CrossRef
[12] Chu, L.C., Goggins, M.G. and Fishman, E.K. (2017) Diagnosis and Detection of Pancreatic Cancer. The Cancer Journal, 23, 333-342. [Google Scholar] [CrossRef
[13] 邵全年, 周辉年, 李向阳, 肖竞英, 焦作义. 基于术前系统免疫炎症指数及控制营养状况评分对胰腺癌根治术后列线图预后预测模型的构建及评价[J/OL]. 中国普外基础与临床杂志, 2021: 1-7[2021-10-09]. http://kns.cnki.net/kcms/detail/51.1505.R.20210818.1107.002.html
[14] Shui, Y., Li, M., Su, J., Chen, M., Gu, X. and Guo, W. (2021) Prognostic and Clinicopathological Significance of Systemic Immune-Inflammation Index in Pancreatic Cancer: A Meta-Analysis of 2,365 Patients. Aging, 13, 20585-20597. [Google Scholar] [CrossRef] [PubMed]
[15] Kim, J.S. and Kang, C.M. (2021) A Systemic Inflammation Response Index (SIRI) Correlates with Survival and Predicts Oncological Outcome in Resected Pancreatic Cancer Following Neo-Adjuvant Chemotherapy. Annals of Hepato-Biliary-Pancreatic Surgery, 25, Article No. S358. [Google Scholar] [CrossRef
[16] Masateru, Y., Tsuyoshi, K., Shintaro, K., Michinori, H., Sho, O., Naruhiko, H., Megumi, Y. and Hideki, O. (2019) Verification of Inflammation-Based Prognostic Marker as a Prognostic Indicator in Hepatocellular Carcinoma. Annals of Gastroenterological Surgery, 3, 667-675. [Google Scholar] [CrossRef] [PubMed]
[17] 南月敏, 高沿航, 王荣琦, 李文刚, 赵素贤, 杨明. 原发性肝癌二级预防共识(2021年版) [J]. 实用肝脏病杂志, 2021, 24(2): 305-318.
[18] 张劲夫, 范正军, 梁润威, 孙涛, 乔兵兵. 术前SIRI和PLR对肝癌切除术后病人生存预测价值分析[J]. 中国实用外科杂志, 2018, 38(2): 210-218.
[19] Atsushi, S., Yukio, I., Kohei, S., Toshifuni, M., Masayuki, O. and Seigo, K. (2006) Prognostic Value of Preoperative Peripheral Blood Monocyte Count in Patients with Hepatocellular Carcinoma. Surgery, 139, 755-764. [Google Scholar] [CrossRef] [PubMed]
[20] Xiao, G.-Q., Liu, C., Liu, D.-L., Yang, J.-Y. and Yan, L.-N. (2013) Neutrophil-Lymphocyte Ratio Predicts the Prognosis of Patients with Hepatocellular Carcinoma after Liver Transplantation. World Journal of Gastroenterology, 19, 8398-8407. [Google Scholar] [CrossRef] [PubMed]
[21] Farhood, B., Najafi, M. and Mortezaee, K. (2019) CD8+ Cytotoxic T Lymphocytes in Cancer Immunotherapy: A Review. Journal of Cellular Physiology, 234, 8509-8521. [Google Scholar] [CrossRef] [PubMed]
[22] Ferlay, J., Soerjomataram, I., Dikshit, R., Eser, S., Mathers, C., Rebelo, M., Parkin, D.M., Forman, D. and Bray, F. (2015) Cancer Incidence and Mortality Worldwide: Sources, Methods and Major Patterns in GLOBOCAN 2012. International Journal of Cancer, 136, E359-E386. [Google Scholar] [CrossRef] [PubMed]
[23] Fock, K.M. (2014) Review Article: The Epidemiology and Prevention of Gastric Cancer. Alimentary Pharmacology & Therapeutics, 40, 250-260. [Google Scholar] [CrossRef] [PubMed]
[24] Chen, W., Zheng, R., Baade, P.D., Zhang, S., Zeng, H., Bray, F., Jemal, A., Yu, X.Q. and He, J. (2016) Cancer Statistics in China, 2015. CA: A Cancer Journal for Clinicians, 66, 115-132. [Google Scholar] [CrossRef] [PubMed]
[25] Siegel Rebecca, L., Miller Kimberly, D. and Jemal, A. (2016) Cancer Statistics, 2016. CA: A Cancer Journal for Clinicians, 66, 7-30. [Google Scholar] [CrossRef] [PubMed]
[26] Shi, H., Jiang, Y., Cao, H., Zhu, H., Chen, B., Ji, W. and Nicolazzo, C. (2018) Nomogram Based on Systemic Immune-Inflammation Index to Predict Overall Survival in Gastric Cancer Patients. Disease Markers, 2018, Article ID: 1787424. [Google Scholar] [CrossRef] [PubMed]
[27] Yang, H., Wei, B. and Hu, B. (2021) Chronic Inflammation and Long-Lasting Changes in the Gastric Mucosa after Helicobacter pylori Infection Involved in Gastric Cancer. Inflammation Research. [Google Scholar] [CrossRef] [PubMed]
[28] 丁平安, 杨沛刚, 张志栋, 田园, 王冬, 赵雪峰, 檀碧波, 刘羽, 李勇, 赵群. 系统性免疫炎症指数与胃癌根治术后患者预后的相关性研究[J]. 中华消化杂志, 2021, 41(8): 534-540.
[29] Folkman, J. (2007) Angiogenesis: An Organizing Principle for Drug Discovery? Nature Reviews Drug Discovery, 6, 273-286. [Google Scholar] [CrossRef] [PubMed]
[30] Rachidi, S., Metelli, A., Riesenberg, B., Wu, B.X., Nelson, M.H., Wallace, C., et al. (2017) Platelets Subvert T Cell Immunity against Cancer via GARP-TGFβ Axis. Science Immunology, 2, Article No. eaai7911. [Google Scholar] [CrossRef] [PubMed]
[31] Zhang, K., Ping, L., Ou, X., Bazhabayi, M. and Xiao, X. (2021) A Systemic Inflammation Response Score for Prognostic Prediction of Breast Cancer Patients Undergoing Surgery. Journal of Personalized Medicine, 11, Article No. 413. [Google Scholar] [CrossRef] [PubMed]
[32] Danforth David, N. (2021) The Role of Chronic Inflammation in the Development of Breast Cancer. Cancers, 13, Article No. 3918. [Google Scholar] [CrossRef] [PubMed]
[33] Chang, S.-L., André, T., Francine, D., Caroline, D. and Nunzio, V. (2021) Associations of Biomarkers of Inflammation and Breast Cancer in the Breast Adipose Tissue of Women with Combined Measures of Adiposity. Journal of Obesity, 2021, Article ID: 3620147. [Google Scholar] [CrossRef] [PubMed]
[34] Göbel, A., Dell’Endice, S., Jaschke, N., Pählig, S., Shahid, A., Hofbauer Lorenz, C. and Rachner Tilman, D. (2021) The Role of Inflammation in Breast and Prostate Cancer Metastasis to Bone. International Journal of Molecular Sciences, 22, Article No. 5078. [Google Scholar] [CrossRef] [PubMed]
[35] 庞健, 王守满, 廖立秋, 刘祥彦. 全身免疫炎症指数与三阴性乳腺癌新辅助化疗疗效及预后的相关性[J/OL]. 中南大学学报(医学版), 2021: 1-8[2021-10-10]. http://kns.cnki.net/kcms/detail/43.1427.R.20210927.1707.002.html
[36] Liu, Q., Tan, Q., Zheng, Y., Chen, K., Qian, C., Li, N., Wang, Q. and Cao, X. (2021) Withdrawal: Blockade of Fas Signaling in Breast Cancer Cells Suppresses Tumor Growth and Metastasis via Disruption of Fas Signaling-Initiated Cancer-Related Inflammation. The Journal of Biological Chemistry, 296, Article No. 100757. [Google Scholar] [CrossRef] [PubMed]